Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA RegistryClaudia Sargas, Cristina Gil, Teresa Bernal et al.|Cancers|2023Cited by 30
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA groupClaudia Sargas, Rosa Ayala, María José Larráyoz et al.|Blood Cancer Journal|2023Cited by 28
Validation of mutated <i>CEBPA</i> bZIP as a distinct prognosis entity in acute myeloid leukemia: a study by the Spanish PETHEMA registryEsther Prados de la Torre, Pau Montesinos, Josefina Serrano et al.|Haematologica|2024Cited by 3
Conventional PCR Versus Next Generation Sequencing for Diagnosis of FLT3, IDH and NPM1 Mutations in Acute Myeloid Leukemia: Results of the PETHEMA PCR-LMA StudyBlanca Boluda, Pau Montesinos, Rebeca Rodríguez‐Veiga et al.|Cancers|2025Cited by 2
Conventional PCR Versus Next Generation Sequencing for Diagnosis of <i>FLT3</i>, <i>IDH</i> and <i>NPM1</i> Mutations in Acute Myeloid Leukemia: Interim Analysis of the PCR-LMA Protocol of the Pethema GroupBlanca Boluda, Pau Montesinos, Claudia Sargas et al.|Blood|2022Cited by 1